CSI Market
Sign In | Register

Cytokinetics Incorporated (CYTK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CYTK Annual Balance Sheets →
This balance sheet overview for Cytokinetics Incorporated spans from Sep 30 2025 to Sep 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent203.43
Restricted Cash3.10
Available-for-sale Securities, Debt Securities, Current MA926.59
Cash & Short-term Investments1,129.00
Accounts receivable33.89
Inventories0.81
Other Current Assets0.00
Prepaid Expense And Other Assets Current22.43
Total Current Assets1,187.15
Equipment/Property/Plant Net76.12
Long-term investments453.63
Other Assets, Noncurrent107.87
Total Assets1,824.78
Liabilities
Accounts Payable, Current AC25.96
Accrued Liabilities, Current AC90.87
Derivative Liability, Current DE31.30
Long-term Debt, Current Maturities LO174.40
Other Liabilities, Current29.23
Deferred Revenue, Current DE1.65
Total Current Liabilities353.42
Long-term debt244.33
Total Long-term Debt244.33
Other liabilities, Noncurrent1,548.20
Operating Lease Liability Current20.96
Total Liabilities2,145.95
Stockholders' Equity
Common Stock Value0.14
Additional Paid In Capital Common Stock3,768.66
Retained Earnings / Accumulated Deficit-4,081.58
Accumulated Other Comprehensive Income-8.39
Other Equity-8.39
Common Stockholder's Equity-321.17
Total Stockholder's Equity-321.17
Liabilities & Stockholder's Equity1,824.78
4 historic quarters locked

Sign in to unlock the full Cytokinetics Incorporated balance sheet history.

Sign In Create Free Account

About Cytokinetics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-447408

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI